GNH USA

Europe — EMA

Octagam 10% (Human Normal Immunoglobulin)

GNH USA supplies Octagam 10% (Human Normal Immunoglobulin), an immunoglobulin therapy for deficiency, ITP, CIDP and Kawasaki disease.

Human Normal Immunoglobulin

Request sourcing

1
Pack/s

What is Human Normal Immunoglobulin?

Human Normal Immunoglobulin, the active ingredient in Octagam 10%, is an immunoglobulin presented as a 10% solution for intravenous use. It replaces deficient antibodies and is used to treat immune deficiencies and certain autoimmune and inflammatory conditions.

GNH USA supplies Octagam 10% as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Human Normal Immunoglobulin used for?

Octagam 10% is an intravenous immunoglobulin used to modify immune system activity in several recognized conditions.

Primary immunodeficiency: provides passive immunity and reduces the frequency of infections. Chronic inflammatory demyelinating polyneuropathy (CIDP): decreases disease activity and improves muscle strength. Immune thrombocytopenic purpura (ITP): raises platelet counts and reduces bleeding risk. Kawasaki disease: lowers the incidence of coronary artery aneurysms in acute disease.

What are the side effects of Human Normal Immunoglobulin?

Common Side Effects: - Headache - Fever or chills - Fatigue - Nausea - Infusion‑related reactions (e.g., flushing, itching) - Mild hypertension

Serious or Rare Side Effects: - Thromboembolic events (stroke, myocardial infarction) - Acute renal failure - Aseptic meningitis - Hemolytic anemia - Anaphylaxis or severe allergic reactions - Severe aseptic meningitis

What precautions apply to Human Normal Immunoglobulin?

Octagam 10% should be used with careful clinical assessment and monitoring. - Renal function: evaluate creatinine and avoid in severe renal impairment. - IgA deficiency: screen patients, as anaphylaxis risk is increased. - Thrombotic risk: avoid in patients with known hypercoagulable states. - Active infection: defer use until infection is controlled. - Concomitant nephrotoxic drugs: adjust therapy to reduce renal stress. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Normal Immunoglobulin interact with?

Octagam 10% may interact with several medications.

Major Interactions (Avoid): - Concurrent use with other IVIG products: risk of hyperviscosity. - Combination with nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increased renal toxicity. - Live vaccines: may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Corticosteroids: may mask infusion reactions. - Immunosuppressants (e.g., azathioprine, cyclophosphamide): heightened infection risk. - Inactivated vaccines: possible reduced immune response. - Diuretics: monitor fluid balance and blood pressure. - ACE inhibitors: observe for additive blood pressure effects.

Frequently asked questions

What conditions is Octagam 10% used to treat?+
Octagam 10% is an intravenous immunoglobulin indicated for primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), immune thrombocytopenic purpura (ITP), and Kawasaki disease. It provides passive immunity and modulates abnormal immune responses in these disorders.
How does Human Normal Immunoglobulin work in Octagam 10%?+
Human Normal Immunoglobulin supplies a broad spectrum of pooled IgG antibodies that neutralize pathogens, bind auto‑antibodies, regulate Fcγ receptors, inhibit complement activation, and suppress pro‑inflammatory cytokines, thereby restoring immune homeostasis.
What is the typical dosing regimen for Octagam 10%?+
The dosing regimen for Octagam 10% is individualized. The prescribing clinician determines the dose, infusion rate, and treatment schedule based on the specific indication, patient weight, and clinical response.
Is Octagam 10% safe to use during pregnancy or breastfeeding?+
Octagam 10% may be used during pregnancy or lactation only if clearly needed. The potential benefits should be weighed against any unknown risks, and the decision should be made by the treating physician in consultation with the patient.
How do I order Octagam 10% from GNH USA?+
To order Octagam 10%, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling), and import documentation.
How does Octagam 10% compare with other IVIG products?+
Octagam 10% is a 10% concentration IVIG derived from EU‑sourced plasma, offering comparable efficacy to other licensed IVIGs. Differences among products may include concentration, stabilizers, and manufacturing processes, which can affect infusion volume, tolerability, and storage requirements.
What are the storage and handling requirements for Octagam 10%?+
Octagam 10% must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Before use, allow the product to reach room temperature if required, and inspect for particulate matter or discoloration.
How is Octagam 10% administered to patients?+
Octagam 10% is administered intravenously by a qualified healthcare professional. The infusion is given through a dedicated IV line, typically over several hours, with the rate adjusted according to patient tolerance and clinical guidelines.
What are the most serious risks associated with Octagam 10%?+
Serious risks include thromboembolic events, acute renal failure, aseptic meningitis, hemolytic anemia, and severe allergic reactions such as anaphylaxis. Patients should be monitored closely during and after infusion for any signs of these complications.
Who should not receive Octagam 10%?+
Octagam 10% is contraindicated in patients with known severe IgA deficiency who have experienced anaphylactic reactions to immunoglobulins, and in individuals with uncontrolled hypercoagulable states or active severe infections without appropriate treatment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Normal Immunoglobulin
Route
Intravenous Use
Manufacturer
Octapharma Benelux S.A.
Origin
EU

Related products

Beriglobin

Beriglobin

Human Normal Immunoglobulin

Csl Behring Gmbh
EU
Beriglobin P

Beriglobin P

Human Normal Immunoglobulin

Csl Behring Gmbh
EU
Beriglobina P

Beriglobina P

Human Normal Immunoglobulin

Csl Behring S.A.
EU
Clairyg

Clairyg

Human Normal Immunoglobulin

Lfb Biomedicaments
EU